跳至主要内容
临床试验/NCT05829642
NCT05829642已完成不适用

Evaluating the Rollout of Estonia's Enhanced Care Management Program

Harvard School of Public Health (HSPH)1 个研究点 分布在 1 个国家目标入组 2,389 人开始时间: 2020年11月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
2,389
试验地点
1
主要终点
Number of Participants with hospital readmission

研究概览

简要总结

Estonia's aging population faces an increasing burden of non-communicable diseases (NCDs) and a growing population suffers with multiple chronic conditions. These changes have reduced well-being and quality of life for many older Estonians, while increasing the use of high cost specialist and emergency care. In response, the Estonia Health Insurance Fund (EHIF) is working to support primary care physicians to improve care for complex patients with multiple chronic conditions. A new EHIF-led program, Enhanced Care Management (ECM), entails training family physicians to identify complex patients, co-develop proactive care plans with them, and to undertake more active outreach to and management of these patients.

详细描述

The Enhanced Care Management (ECM) intervention consists of training and coaching family physicians and their teams to develop holistic care and pro-active outreach plans for chronically ill patients or those vulnerable to developing chronically illnesses, as identified and agreed between the enrolled providers and the Estonian Health Insurance Fund (EHIF). Under ECM, patients covered by EHIF and suffering from chronic diseases such as diabetes and cardiovascular diseases will be proactively engaged and monitored by primary care providers to provide better care and to prevent health deterioration.

Risk-stratified care management for chronic conditions was first introduced in Estonia in 2017 to better support high-risk patients with an assortment of chronic conditions and an increased risk of healthcare utilization. The Enhanced Care Management (ECM) program is intended to improve the quality of care provided to complex patients with qualifying chronic conditions, by increasing the use of preventive care, improving coordination of care across health system levels, and increasing patient involvement in care. These elements can improve patient health and quality of life, and may reduce the need for curative and higher-level medical services-for example, by supporting patients with type 2 diabetes to improve their diet and increase physical activity to limit further deterioration in their health and use of emergency or specialty health services.

In 2017, the World Bank, EHIF and the Estonian Family Physicians Association launched a pilot of risk-stratified care management with a very small number of volunteering primary health care providers. From January to February 2017, a digital environment was developed to monitor patients for family physicians. It contains important data of risk patients (health indicators, medical history, socio-economic background) which can be accessed digitally by health care providers. This allowed family physicians and nurses to monitor health indicators and treatment goals of high-risk patients and track the implementation of the treatment plan.

The family physician and nurse's responsibilities involved assessing patient needs, creating treatment plans, coordinating health-related activities, and working with a social worker to provide social support. During the pilot project, family physicians collaborated with hospitals to track patient outcomes. Results of the initial pilot convinced EHIF that it would be beneficial to test expansion of the ECM model nationally, so a full-scale study was launched during 2020 to include a representative sample of clinics and their eligible patients nationwide.

In this study, the research team will conduct a randomized controlled trial in partnership with EHIF to evaluate the impact of ECM training for physicians. The RCT will have enrolled a randomly selected 97 family physicians out of the 786 family physicians practicing in Estonia. Among those physicians' 6,739 ECM-eligible patients, 2,389 patients will have been randomly selected for enrollment into the ECM program. Using administrative records, the study will evaluate the effects of ECM enrollment on: (1) health care utilization; (2) provider management of tracer conditions; and (3) markers of quality of care such as hospital admission for primary health care-sensitive conditions.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • identified by general practitioner as having multiple chronic health conditions including type 2 diabetes, hypertension, and obesity
  • Exclusion Criteria (for patients):
  • terminal illness; acute cancer (cancer in treatment), schizophrenia, dialysis due to renal failure, congenital malformations requiring specialized care, and rare diseases; patients with more than 7 chronic conditions
  • Exclusion Criteria (for clinics) Having participated in ECM pilot study; not being currently operational; or having five or more practicing providers in the clinic

排除标准

  • 未提供

结局指标

主要结局

Number of Participants with hospital readmission

时间窗: through study completion, an average of 2 years

Inpatient readmission within 90 days after any previous inpatient admission

Number of Participants with primary health care utilization

时间窗: through study completion, an average of 2 years

number of primary health care service interactions

Number of Participants with inpatient care interactions

时间窗: through study completion, an average of 2 years

number of hospitalizations

Number of Participants with emergency department visits

时间窗: through study completion, an average of 2 years

number of emergency department visits for any reason

Number of Participants with outpatient services

时间窗: through study completion, an average of 2 years

number of times ambulatory services accessed

Number of Participants with avoidable hospital admissions

时间窗: through study completion, an average of 2 years

number of hospital admissions with asthma, COPD, diabetes, congestive heart failure, or hypertension as primary diagnosis

次要结局

  • Number of Participants with outpatient post-visit services(through study completion, an average of 2 years)
  • Number of diabetes, hypertension and myocardial infarction patients with monitoring of creatinine(through study completion, an average of 2 years)
  • Number of diabetes, hypertension and myocardial infarction patients with monitoring of cholesterol levels and fractions(through study completion, an average of 2 years)
  • Number of Participants with inpatient post-hospitalization services(through study completion, an average of 2 years)
  • Number of Participants with telephone follow up contacts(through study completion, an average of 2 years)
  • Number of diabetes, hypertension and myocardial infarction patients with monitoring of glycosylated Hb (HbA1C)(through study completion, an average of 2 years)
  • Number of Participants with chronic illness-related follow up contacts(through study completion, an average of 2 years)
  • Number of hypertension care (high risk patients), diabetes, and myocardial infarction patients(through study completion, an average of 2 years)
  • Number of diabetes patients with appropriate prescriptions(through study completion, an average of 2 years)
  • Number of participants with prescriptions obtained(through study completion, an average of 2 years)
  • Number of myocardial infarction patients with appropriate statin prescription(through study completion, an average of 2 years)
  • Number of myocardial infarction patients with appropriate beta-blockers prescription(through study completion, an average of 2 years)
  • Number of participants with inadequate acute care follow up(through study completion, an average of 2 years)
  • Number of participants with incomplete discharge from acute care(through study completion, an average of 2 years)
  • Number of participants with hypertension (moderate or high-risk patients) with appropriate drug prescription(from enrollment to study completion)
  • Number of participants with hyperthyroidism monitoring with TSH adequately measured(through study completion, an average of 2 years)
  • Number of participants with new diagnosis of tracer conditions(through study completion, an average of 2 years)
  • Number of hypertension patients (all risk levels) with drug prescription appropriate(through study completion, an average of 2 years)

研究者

发起方
Harvard School of Public Health (HSPH)
申办方类型
Other
责任方
Principal Investigator
主要研究者

Kevin Croke

Assistant Professor of Global Health

Harvard School of Public Health (HSPH)

研究点 (1)

Loading locations...

相似试验